Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Daily Values
Growth Metrics
Income Statement
Shares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares Outstanding
Ratios

Haoxi Health Technology (HAO) Shares Outstanding (2023 - 2025)

Haoxi Health Technology has reported Shares Outstanding over the past 2 years, most recently at $2.2 million for Q2 2025.

  • Quarterly results put Shares Outstanding at $2.2 million for Q2 2025, changed N/A from a year ago — trailing twelve months through Jun 2025 was $2.2 million (changed N/A YoY), and the annual figure for FY2025 was $2.2 million, changed.
  • Shares Outstanding for Q2 2025 was $2.2 million at Haoxi Health Technology, up from $1.2 million in the prior quarter.
  • Over the last five years, Shares Outstanding for HAO hit a ceiling of $2.2 million in Q2 2025 and a floor of $1.2 million in Q2 2023.